The first trial over claims that the heartburn medication Zantac causes cancer has commenced in Chicago, Illinois. The proceedings, which began with jury selection on April 30, are taking place in Cook County. This trial marks a significant legal examination of the allegations against Zantac, previously marketed by GSK and other companies. Plaintiff Angela Valadez, who alleges that her use of Zantac led to her developing colon cancer, is one of the individuals at the center of these claims.
The first-ever trial over claims that over-the-counter heartburn drug Zantac causes cancer starts Thursday in Cook County. https://t.co/MQ2WNY2HzD
Jury selection in the first trial over claims that heartburn drug Zantac, which was sold by GSK and other companies, causes cancer began on April 30. Plaintiff Angela Valadez alleged that she got colon cancer from the medication https://t.co/rZVxDXmKWJ https://t.co/m4fPrd98ka
First trial over Zantac cancer claims set to begin in Chicago @brenpiers https://t.co/rZVxDXmKWJ https://t.co/VWy2Xp5w1q
First trial over Zantac cancer claims set to begin in Chicago https://t.co/NCrfMhehvh https://t.co/VugUtseeOV
⚠️ FIRST TRIAL OVER ZANTAC CANCER CLAIMS SET TO BEGIN IN CHICAGO Full Story → https://t.co/ZzlDI8hFVL The first trial over claims that blockbuster heartburn drug Zantac, once sold by GSK and other companies, causes cancer is set to begin this week in Chicago.
Jury selection in the first trial over claims that discontinued heartburn drug Zantac, which was sold by GSK and others, causes cancer is scheduled to begin in Illinois state court. Subscribe to The Daily Docket: https://t.co/tPd4HcaOFI https://t.co/QGEwXWQcQY